Michael A. Rulli Stock Trades

Michael A. Rulli Stock Trading Profile | Quantellect Michael A. Rulli Stock Trading Profile

Michael A. Rulli's disclosures show a burst of transactions reported in a single filing rather than a steady drip of disclosures. Of the 32 disclosed transactions in the record, 17 occurred in 2026, up from 12 in 2025 and just 3 in the tail end of 2024. All 32 transactions were disclosed on the same date, August 7, 2026, while their transaction dates span November 2024 through August 2026. All 32 transactions are attributed to Rulli himself (SELF), with no spousal, dependent, joint, or unknown-attribution activity in the data.

The overall split leans slightly toward selling: 18 sales against 14 purchases across the full disclosure history. The yearly balance varies. In 2026, purchases and sales are close to even at 9 and 8, while 2025 was more sale-heavy at 5 purchases versus 7 sales. The three transactions dated in 2024 were sales only, in Pfizer, Thermo Fisher Scientific, and ServiceNow.

A trading pattern concentrated in mega-cap technology

Sector activity is heavily skewed. Information Technology accounts for 15 of the 32 disclosed transactions, more than double the next closest category, Communication Services, at 6. Health Care follows with 5, and the remaining transactions are scattered one or two at a time across Consumer Discretionary, Consumer Staples, Financials, Industrials, and Real Estate. Within Information Technology, the activity includes familiar hardware, semiconductor, and software names: Apple, Microsoft, NVIDIA, Micron, KLA Corporation, ServiceNow, Oracle, and Palantir Technologies all appear.

The most frequently disclosed securities by transaction count are Apple, Alphabet Class A, Eli Lilly, Meta Platforms, Microsoft, and NVIDIA, each showing up three times in the disclosure record. Amazon.com and Palantir Technologies each appear twice. Several of these names show both purchase and sale activity. Meta was purchased on 2025-09-18, sold on 2026-01-09, and purchased again on 2026-05-06. Microsoft was purchased on 2026-02-05, sold on 2026-02-20, and sold again on 2026-06-25. NVIDIA was sold on 2025-07-31, purchased on 2025-08-01, and purchased again on 2026-06-25. Palantir was purchased on 2026-01-09 and sold on 2026-05-06. This repeated purchase-and-sale activity, disclosed together on a single date, centers on a fairly narrow list of large, liquid technology and communication services stocks.

Eli Lilly stands out as the one Health Care name with the same kind of repeated activity: sold on 2025-12-02, purchased on 2026-01-02, and sold again on 2026-07-01. The rest of the Health Care disclosures, Pfizer and Thermo Fisher Scientific, were single sales from late 2024 and have not reappeared since.

Outside of technology and health care, the record shows single, smaller footprints: a Coca-Cola purchase in December 2025, a Prudential Financial sale in May 2025, a GE Vernova sale in October 2025, and a Crown Castle sale on 2026-08-06, the most recent transaction in the packet. Every disclosed transaction, without exception, falls in the $1,001 to $15,000 range, the lowest reporting bracket described in the House Committee on Ethics financial disclosure instruction guide, so the disclosed dollar scale is modest even though the transaction count has picked up.

The companies behind these tickers span some of the most closely watched businesses in the market. Apple, Microsoft, Alphabet, Amazon, Meta, and NVIDIA recur across the disclosures and span consumer hardware, cloud infrastructure, search and advertising, e-commerce, social platforms, and accelerated computing. KLA Corporation and Micron sit further down the semiconductor supply chain, in process-control equipment and memory respectively. Eli Lilly and Pfizer are large pharmaceutical makers with products across diabetes, obesity, oncology, and vaccines. Crown Castle owns roughly 40,000 U.S. cell towers and is classified as a specialized communications-infrastructure REIT. GE Vernova operates across power, wind, and electrification, including power-generation and grid technologies. Each is a name investors already track closely, so the disclosures mostly confirm activity in companies already at the center of market attention rather than introducing lesser-known names.

Quantellect's scoring model assigns Rulli's disclosed trading activity a score of 16 as of August 21, 2026, placing him in the "weak" tier and ranking 65th in a 76-member scored cohort, within a limited-coverage data state.

Disclosure and data notes

This profile is built from Michael A. Rulli's official financial disclosure filings and covers transaction disclosures only. Transaction amounts are presented in ranges rather than as exact dollar figures. The statutory framework for periodic transaction reporting is set out in the Stop Trading on Congressional Knowledge (STOCK) Act of 2012, while filing and reporting mechanics are described in the House Committee on Ethics financial disclosure instruction guide. The underlying filing referenced throughout this profile is available here. The dates attached to individual transactions above are transaction dates; August 7, 2026, is the disclosure date for every transaction in this record.